The World Health Organization has approved a version of a widely used cholera vaccine that could help address a surge in cases that has depleted the global vaccine stockpile and left poorer countries scrambling to contain epidemics.
WHO authorized the vaccine, made by EuBiologics, which also makes the formulation now used, last week. The new version, called Euvichol-S, is a simplified formula that uses fewer ingredients, is cheaper, and can be made more quickly than the old version.
The vaccine was shown to be help preventing the diarrheal disease in late stage research conducted in Nepal.
WHO’s approval means donor agencies like the vaccines alliance Gavi and UNICEF can now buy it for poorer countries. Leila Pakkala, director of UNICEF’s supply division, said in a statement that the agency will be able to boost supplies by more than 25%.
Police detective lays bare Hells Angels' twisted links to the MAFIA
3 scientists share 2023 Nobel Prize in Physics
China's intelligently upgraded highways top 3,500 kilometers
China launches new remote sensing satellite
EU proposes youth mobility agreement with UK to help youngsters travel, work and live in both areas
Chinese scientists develop fast
China, Micronesia to elevate ties
Nicola Peltz Beckham gushes over mother
Bengals likely to look for an offensive tackle and run
3 scientists share 2023 Nobel Prize in Physics